Alpha-Methylacyl-CoA Racemase (AMACR), a Potential New Biomarker for Glioblastoma

Alpha-Methylacyl-CoA Racemase (AMACR), a Potential New Biomarker for Glioblastoma

Alpha-Methylacyl-CoA racemase (AMACR), which was initially discovered as a prostate cancer marker, is critical for the chiral inversion mechanism of branched-chain fatty acids. However, the function of AMACR in brain tumors has not been investigated. In this study, AMACR appeared to be involved in g...

תיאור מלא

מידע ביבליוגרפי
Main Authors: Hyunji Lee, Minhee Kim, Seon-Hwan Kim, Quangdon Tran, Gyeyeong Kong, Chaeyeong Kim, So Hee Kwon, Jisoo Park, Jin Bong Park, Sungjin Park, Jongsun Park
פורמט: Article
שפה:English
יצא לאור: Frontiers Media S.A. 2020-10-01
סדרה:Frontiers in Oncology
נושאים:
alpha-methylacyl-CoA racemase
glioblastoma
brain
cancer
biomarker
גישה מקוונת:https://www.frontiersin.org/article/10.3389/fonc.2020.550673/full

אינטרנט

https://www.frontiersin.org/article/10.3389/fonc.2020.550673/full

פריטים דומים